FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W56664697> ?p ?o ?g. }

• W56664697 endingPage "1535" @default.
• W56664697 startingPage "1529" @default.
• W56664697 abstract "The aim of the present study was to determine whether troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus (NIDDM).Increased in-stent restenosis in patients with diabetes mellitus is due to accelerated neointimal tissue proliferation after coronary stent implantation. Troglitazone inhibits intimal hyperplasia in experimental animal models.We studied 62 stented lesions in 52 patients with plasma glucose levels (PG) > or = 11.1 mmol/liter at 2 h after 75 g oral glucose load. The study patients were randomized into two groups: the troglitazone group of 25 patients with 29 stents, who were treated with 400 mg of troglitazone, and the control group of 27 patients with 33 stents. All patients underwent oral glucose tolerance tests before and after their six-month treatment period. The sum of PG (sum of PG) and the sum of insulin levels (sum of IRI) were measured. Serial (postintervention and at six-month follow-up) intravascular ultrasound studies were performed. Cross-sectional images within stents were taken at every 1 mm, using an automatic pullback. Stent areas (SA), lumen areas (LA), and intimal areas (IA = SA - LA) were measured and averaged over a number of selected image slices. The intimal index was calculated as intimal index = averaged IA/averaged SA x 100%.There were no differences between the two groups before treatment in sum of PG (31.35 +/- 3.07 mmol/liter vs. 32.89 +/- 4.87 mmol/liter, respectively, p = 0.2998) and sum of IRI (219.6 +/- 106.2 mU/liter vs. 209.2 +/- 91.6 mU/liter, respectively, p = 0.8934). However, reductions in sum of PG at the six-month follow-up in the troglitazone group were significantly greater than those in the control group (-21.4 +/- 8.8% vs. -4.5 +/- 7.4%, respectively, p < 0.0001). Likewise, decreases in sum of IRI were greater in the troglitazone-treated group (-31.4 +/- 17.9% vs. -1.9 +/- 15.1%, respectively, p < 0.0001). Although, there were no differences between the two groups in SA at postintervention (7.4 +/- 2.2 mm2 vs. 7.3 +/- 1.7 mm2, respectively, p = 0.9482) and at follow-up (7.3 +/- 2.3 mm2 vs. 7.3 +/- 1.8 mm2, respectively, p = 0.2307), the LA at follow-up in the troglitazone group was significantly greater than that in the control group (5.3 +/- 1.7 mm2 vs. 3.7 +/- 1.7 mm2, respectively, p = 0.0002). The IA at follow-up in the troglitazone group was significantly smaller than that in the control group (2.0 +/- 0.9 mm2 vs. 3.5 +/- 1.8 mm2, respectively, p < 0.0001). This was also true for intimal index (27.1 +/- 11.5% vs. 49.0 +/- 14.4%, respectively, p < 0.0001).Serial intravascular ultrasound assessment shows that administration of troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with NIDDM." @default.
• W56664697 created "2016-06-24" @default.
• W56664697 creator A5000322274 @default.
• W56664697 creator A5021559372 @default.
• W56664697 creator A5027124029 @default.
• W56664697 creator A5045806272 @default.
• W56664697 creator A5055186772 @default.
• W56664697 creator A5073749409 @default.
• W56664697 creator A5077761521 @default.
• W56664697 date "2000-11-01" @default.
• W56664697 modified "2023-10-10" @default.
• W56664697 title "Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non–insulin dependent diabetes mellitus" @default.
• W56664697 cites W1966090243 @default.
• W56664697 cites W1969602771 @default.
• W56664697 cites W1969756099 @default.
• W56664697 cites W1971217345 @default.
• W56664697 cites W1972717487 @default.
• W56664697 cites W1985317064 @default.
• W56664697 cites W1986377836 @default.
• W56664697 cites W1991592955 @default.
• W56664697 cites W1996271817 @default.
• W56664697 cites W1997582444 @default.
• W56664697 cites W2003420643 @default.
• W56664697 cites W2003856834 @default.
• W56664697 cites W2010203748 @default.
• W56664697 cites W2016682279 @default.
• W56664697 cites W2017072501 @default.
• W56664697 cites W2036720093 @default.
• W56664697 cites W2036872051 @default.
• W56664697 cites W2039928997 @default.
• W56664697 cites W2052035619 @default.
• W56664697 cites W2054683048 @default.
• W56664697 cites W2072289636 @default.
• W56664697 cites W2076552301 @default.
• W56664697 cites W2080744024 @default.
• W56664697 cites W2086305057 @default.
• W56664697 cites W2090412760 @default.
• W56664697 cites W2090635919 @default.
• W56664697 cites W2116404316 @default.
• W56664697 cites W2118678876 @default.
• W56664697 cites W2135097963 @default.
• W56664697 cites W2136427955 @default.
• W56664697 cites W2141709092 @default.
• W56664697 cites W2320006945 @default.
• W56664697 cites W2323262681 @default.
• W56664697 cites W2324489407 @default.
• W56664697 cites W2335922553 @default.
• W56664697 cites W4246895968 @default.
• W56664697 doi "https://doi.org/10.1016/s0735-1097(00)00895-0" @default.
• W56664697 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11079654" @default.
• W56664697 hasPublicationYear "2000" @default.
• W56664697 type Work @default.
• W56664697 sameAs 56664697 @default.
• W56664697 citedByCount "185" @default.
• W56664697 countsByYear W566646972012 @default.
• W56664697 countsByYear W566646972013 @default.
• W56664697 countsByYear W566646972014 @default.
• W56664697 countsByYear W566646972015 @default.
• W56664697 countsByYear W566646972016 @default.
• W56664697 countsByYear W566646972017 @default.
• W56664697 countsByYear W566646972018 @default.
• W56664697 countsByYear W566646972020 @default.
• W56664697 countsByYear W566646972022 @default.
• W56664697 countsByYear W566646972023 @default.
• W56664697 crossrefType "journal-article" @default.
• W56664697 hasAuthorship W56664697A5000322274 @default.
• W56664697 hasAuthorship W56664697A5021559372 @default.
• W56664697 hasAuthorship W56664697A5027124029 @default.
• W56664697 hasAuthorship W56664697A5045806272 @default.
• W56664697 hasAuthorship W56664697A5055186772 @default.
• W56664697 hasAuthorship W56664697A5073749409 @default.
• W56664697 hasAuthorship W56664697A5077761521 @default.
• W56664697 hasBestOaLocation W566646971 @default.
• W56664697 hasConcept C126322002 @default.
• W56664697 hasConcept C126894567 @default.
• W56664697 hasConcept C127078168 @default.
• W56664697 hasConcept C131631996 @default.
• W56664697 hasConcept C134018914 @default.
• W56664697 hasConcept C141071460 @default.
• W56664697 hasConcept C164705383 @default.
• W56664697 hasConcept C170493617 @default.
• W56664697 hasConcept C2776931568 @default.
• W56664697 hasConcept C2778095995 @default.
• W56664697 hasConcept C2778150266 @default.
• W56664697 hasConcept C2778283817 @default.
• W56664697 hasConcept C2778583881 @default.
• W56664697 hasConcept C2779306644 @default.
• W56664697 hasConcept C2779751240 @default.
• W56664697 hasConcept C2992686903 @default.
• W56664697 hasConcept C555293320 @default.
• W56664697 hasConcept C71924100 @default.
• W56664697 hasConcept C90924648 @default.
• W56664697 hasConceptScore W56664697C126322002 @default.
• W56664697 hasConceptScore W56664697C126894567 @default.
• W56664697 hasConceptScore W56664697C127078168 @default.
• W56664697 hasConceptScore W56664697C131631996 @default.
• W56664697 hasConceptScore W56664697C134018914 @default.
• W56664697 hasConceptScore W56664697C141071460 @default.

• next